EMA Upholds Refusals for Pediatric Pain Spray and NPC Drug
Summary
The CHMP has confirmed refusal of KemSu for pediatric acute pain and Meplyffa for Niemann-Pick disease type C after reexamination, citing efficacy concerns. Medscape News Europe
Description from Medscape.
Who is covering this
-
EMA Upholds Refusals for Pediatric Pain Spray and NPC Drug
The CHMP has confirmed refusal of KemSu for pediatric acute pain and Meplyffa for Niemann-Pick disease type C after reexamination, citing efficacy concerns. Medscape News Europe
Comments
Comments need JavaScript.